Recall Z-0316-2027

Recall number
Z-0316-2027
Event number
99851
Firm
Tandem Diabetes Care, Inc.
Firm FEI
3007981285
Product code
QFG
Status
Open, Classified
Initiated
2026-09-23
Posted
2026-10-30
Root cause
Process change control
510(k) numbers
K240309, K223213, K233044, K241078, K253074, K213134, K234027, K263422, K261672, K231826, K251032, K253976, K250792, K253743, K232380, K203234, K201214, K213536, K233952, K241178, K191679, K250930, K260001, K253470, K223846, K252770, K231485, K230545, K203768

Product#

Tandem Mobi Insulin Pump, Models: 1004004, 1010750, 1012676, 1012719, 1013655, 1013656, 1013501, 1013700, 1014081, 1014801, 1014811, 1014813, 1014936, 1016911, 1016912, 1016913, 1016914, 1018075, 1018077, 1018078

Reason for Recall#

Tandem Diabetes Care, Inc. ( Tandem ) has identified that certain Tandem Mobi insulin pumps may generate false-positive occlusion alarms when no actual insulin flow obstruction is present. Investigation determined that increased friction within the drive module can reduce available motor power and, under certain conditions, cause motor speed to fall below the occlusion detection threshold. As a result, the pump may incorrectly detect an occlusion condition and suspend insulin delivery. When an occlusion alarm occurs, insulin delivery remains suspended until the user acknowledges the alarm and resumes therapy. Repeated false-positive occlusion alarms, if not addressed promptly, may result in interruptions of insulin delivery that can increase the risk of elevated blood glucose levels. In severe cases, hyperglycemia may require medical intervention or hospitalization.